Jennifer A. Stone
Known title: VP, Chief HR OfficerCIK: 0002025056
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Accendra Health Receives NYSE Continued Listing Notice. Accendra Health received a notice from the NYSE regarding continued listing standards, with the company stating its intent to cure the deficiency. This regulatory development adds pressure to a stock that is already trading near its 52-week low. Additionally, Bank of America disclosed a 10.8% stake in the company as of September 30.
Transaction History
| MAS | ▼ Sell | Tax Withholding | 4,767 | $343K | 2/25/2026 | View on chart |
| MAS | ▲ Buy | Grant | 4,060 | $0 | 2/12/2026 | View on chart |
| MAS | ▲ Buy | Grant | 26,140 | $0 | 1/5/2026 | View on chart |
| ACH | ▼ Sell | Tax Withholding | 5,764 | $37K | 6/3/2025 | View on chart |
| ACH | ▲ Buy | Grant | 59,013 | $0 | 3/3/2025 | View on chart |
| ACH | ▲ Buy | Grant | 57,078 | $0 | 6/3/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Masco: Longtime leader dies; Q3 earnings date set
Richard Manoogian, a longtime Masco leader and philanthropist, has died at age 90. The company also announced the date for its third-quarter 2026 earnings release and conference call. Recent analyst notes highlight Masco's limited exposure to new construction as a positive factor, while others point to company-specific growth drivers supporting the stock despite soft end markets.
Masco: Longtime leader dies; Q3 earnings date set. Richard Manoogian, a longtime Masco leader and philanthropist, has died at age 90. The company also announced the date for its third-quarter 2026 earnings release and conference call. Recent analyst notes highlight Masco's limited exposure to new construction as a positive factor, while others point to company-specific growth drivers supporting the stock despite soft end markets.